IP Library Granted Patent US 10,968,207
Granted Patent B2
US 10,968,207 · App. 16/854,480 · Granted Apr 6, 2021

Methods for preparing oltipraz

Inventor: Bomi P. Framroze (Mumbai, IN)
Assignee: ST IP Holding AG
C07D409/04C07D241/12C07D241/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,968,207
App. No.
16/854,480
Granted
Apr 6, 2021
Kind
B2
Abstract

The invention provides improved methods of synthesizing oltipraz, which result in higher overall yield and better purity of the desired product.

Claims (14)

1. A method of making a composition comprising oltipraz, comprising the steps of:

(i) reacting a quantity of pyrazine-2-carboxylic acid methyl ester with methyl propionate to form methyl 2-methyl-3-oxo-3-(pyrazin-2-yl)propanoate, wherein the reaction is carried out in the presence of a base comprising potassium t-butoxide or sodium pentanoate, and a solvent comprising 1,4-dioxane in tetrahydrofuran (THF), wherein the ratio of 1,4-dioxane in the THF is at least about 1:5;

(ii) adding at least one aqueous liquid to quench the reaction in Step (i);

(iii) adding a nonpolar organic solvent and an ionic salt, thereby forming a composition comprising an aqueous component and an organic component, wherein the organic component comprises the nonpolar solvent and methyl 2-methyl-3-oxo-3-(pyrazin-2-yl) propanoate;

(iv) separating the organic component from the aqueous component;

(v) reacting the methyl 2-methyl-3-oxo-3-(pyrazin-2-yl)propanoate ester in the organic component with P 2 S 5 in the presence of a nonpolar organic solvent to form 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione (oltipraz).

2. A method according to claim 1 , wherein the ratio of 1,4-dioxane to THF in Step (i) is from about 1:5 to about 1:3.

3. A method according to claim 2 , wherein, the ratio of 1,4-dioxane to THF is about 1:4.

4. A method according to claim 1 , wherein the base comprises potassium t-butoxide.

5. A method according to claim 1 , wherein the mole ratio of the base to methyl propionate is from about 3:1 to about 1:1.

6. A method according to claim 1 , wherein the nonpolar organic solvent used in Step (iii) comprises toluene.

7. A method according to claim 1 , wherein the nonpolar organic solvent in Step (v) comprises toluene.

8. A method according to claim 1 , wherein the nonpolar solvent in Step (iii) is the same nonpolar solvent used in Step (v).

9. A method according to claim 1 , wherein the yield of oltipraz is greater than 21% based on the amount of pyrazine-2-carboxylic acid methyl ester.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2025
From: ZPNE GROUP GMBH
To: SUPPORTIVE THERAPEUTICS AG
Reel/Frame 071622/0178 →
MERGER BY ACQUISITION Recorded Jul 3, 2025
From: ST IP HOLDING AG
To: ZPNE GROUP GMBH
Reel/Frame 071925/0865 →
LIEN Recorded Jun 17, 2022
From: ST IP HOLDING AG
To: FOLEY HOAG LLP
Reel/Frame 060520/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2020
From: FRAMROZE, BOMI P.
To: ST IP HOLDING AG
Reel/Frame 052474/0303 →
Priority Claims (1)
IN 1891/DEL/2015 · Jun 25, 2015 · national
Continuity (4)
Continuation 16784915 · Feb 7, 2020
Continuation 16041282 · Jul 20, 2018
Continuation 14823256 · Aug 11, 2015
Related Publication 20200247791A1 · Aug 6, 2020